In addition, in response to factors secreted in the TME, Tregs are recruited from the circulation, further contributing to diminishing tumor immune surveillance by secreting IL-10 and TGF-β [53,54], or possibly by killing anti-tumor effectors and APCs [54]. The gene discussed is IL10; the disease is neoplasm.